Dr. Christopher Bobby Nnaoma, MD

Dr. Nnaoma practices at Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health.

Dr. Nnaoma's NPI, 1164963476, was assigned on March 20, 2017. Dr. Nnaoma holds New Jersey license 25MA10784200.

Dr. Nnaoma's primary practice is Newark Beth Israel Medical Center, at 201 Lyons Ave, Newark, NJ 07112 in Essex County. The practice phone is (973) 926-7000.

Dr. Nnaoma's primary practice is Newark Beth Israel Medical Center in Newark, New Jersey, part of RWJBarnabas Health. Dr. Nnaoma is also affiliated with Hackensack Meridian Mountainside Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Nnaoma to 1 more hospital and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nnaoma practices, 3 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Nnaoma's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Nnaoma is licensed in New Jersey.

CMS data shows 286 Medicare services from Dr. Nnaoma across 7 procedure codes in 2024, for 143 Medicare patients. Medicare paid $23,380 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 143 Medicare patients who saw Dr. Nnaoma in 2024. The largest group is 75 to 84, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nnaoma's median patient age at 72, with 55% women.

In 2024, Dr. Nnaoma wrote 213 Medicare Part D claims for 77 patients. 78% of them were for generic drugs. CMS names the drug for 75 of them, across 5 drugs with 11 or more claims each, at $673 in total drug cost. In 2023, CMS named 23 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Nnaoma for performance year 2024, reported through an alternative payment model (APM). Dr. Nnaoma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of coronary angioplasty and stenting by Dr. Nnaoma, more than 53% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Nnaoma, published from 2018 to 2021. 2019 was the busiest year, with 8. The most frequent topics are Tomography, X-Ray Computed. Dr. Nnaoma has published most often in Am J Case Rep. Dr. Nnaoma's most frequent co-authors are Jose R. Bustillo, DO, Ogechukwu Zara Chika-Nwosuh, MD and Ikechukwu Valentine Mbonu, MD.

CMS Open Payments shows 84 general payments to Dr. Nnaoma from 23 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 51% of the total. Medtronic, Inc. paid the most, $4,586.